IGF::OT::IGF - RESEARCH&DEVELOPMENT IN SUPPORT OF THE US ARMY MEDICAL MATERIEL DEVELOPMENT ACTIVITY (USAMMDA) FOR THE PERFORMANCE OF A PHASE I, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE LONG-TERM OPHTHALMIC SAFETY OF TAFENOQUINE VERSUS PLACEBO.
$24,654,606
| Recipient | DYNPORT VACCINE COMPANY LLC UEI LXNEGTYDR755 |
|---|---|
| Award ID | 0002 |
| Award amount | $24,654,606 |
| Award type | DELIVERY ORDER |
| Awarding agency | Department of Defense — Department of the Army |
| NAICS | 541712 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) |
| PSC | AJ53 |
| Start date | Mar 22, 2017 |
| End date | Jul 31, 2022 |
| Place of performance | — |
| Record updated | Nov 2, 2021 |
View the official award record
More awards won by DYNPORT VACCINE COMPANY LLC
EARLY PHASE CLINICAL TRIAL UNITS (EPCTU)
Department of Health and Human Services · $346,610,277 · Jan 14, 2022
PROGRAM REPORTING - TECHNICAL
Department of Defense · $257,417,661 · May 9, 2013
"EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES.
Department of Health and Human Services · $136,588,701 · Sep 30, 2025
DIAGNOSTIC PRE-CLINICAL SERVICES PROGRAM -IDIQ - DYNPORT
Department of Health and Human Services · $36,000,000 · Jun 20, 2023
PRECLINICAL SERVICES FOR BIOPHARMACEUTICAL PRODUCT DEVELOPMENT: IDIQ PARENT CONTRACT
Department of Health and Human Services · $30,000,000 · Sep 8, 2023
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids